Dr. Carter is Co-Founder and CSO of HDT Bio Corp, a Seattle, WA based startup company developing vaccines and immune therapies. He is a biochemist/biophysicist and has founded five biotech companies. In 1998 he led the first new recombinant tuberculosis vaccine into human clinical trials. In 2004, he started and was the CEO of PAI Life Sciences, a bioinformatics company with proprietary drug discovery technology using artificial neural nets to identify new vaccine antigens, drugs and diagnostics. In 2005 he co-founded Dharma Therapeutics Inc., a specialty pharmaceutical company focused on drug delivery where he worked as the Chief Scientific Officer (CSO) prior to its Japanese parent company going public in Singapore. In 2009 he helped start a company focused on improving cancer outcomes, Compliment Corp. He is on the board of two Seattle biotechnology companies and acts as a scientific advisor for vaccine and global health institutes as well as having two affiliate professor appointments at the University of Washington in the School of Medicine and in Global Health. He is inventor on over 160 patents and patent applications and has authored over 100 publications.